VANCOUVER, British Columbia & SAN DIEGO--(BUSINESS WIRE)--Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that it has appointed Kenneth Buechler, Ph.D., to its Board of Directors. Dr. Buechler was a co-founder of BioSite and served as the Company’s president until it was sold to Inverness for $1.9B last July.
